September 11th, 2014
Is This Trial Ethical?
CardioExchange Editors, Staff
Does the need for a new placebo-controlled trial of epinephrine in cardiac arrest justify questionable consent procedures?
July 7th, 2014
HEAT-PPCI: Heparin Beats Bivalirudin in Primary PCI
Larry Husten, PHD
Although there is broad consensus in the medical community that primary PCI is the best treatment for MI patients when it can be delivered promptly, there is no agreement about the best accompanying drug regimen, which usually entails a combination of antiplatelet and antithrombotic drugs. The role of one antithrombotic, bivalirudin (Angiomax, The Medicines Company) has […]
May 20th, 2014
Hopes and Beliefs: How Patients Respond to Informed-Consent Tools
Todd K. Rosengart, MD
Todd Rosengart answers Harlan Krumholz’s questions about his study of informed consent in patients scheduled for PCI.
January 5th, 2011
Do Sleep-Deprived Invasive Cardiologists Cause Complications?
Richard A. Lange, MD, MBA
In an NEJM perspective, the former president of the Sleep Research Society reports an 83% increase in the risk of surgical complications in patients undergoing elective daytime surgery performed by attending surgeons who had a <6-hour opportunity for sleep between procedures during a previous on-call night. He argues that physicians who have been awake for […]
NEJM Journal Watch — Recent Cardiology Articles- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
- Can Genetic and Social Risk Scores Improve Cardiac Risk Prediction?
- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?
- Are Angiographically-Derived Coronary Physiology Measurements Ready for Use in the Cath Lab?